Controneo Pat

Avg. Two Year Performance

No purchase track record
(4%) Avg. Sale Return
(2%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(1%)(9%)(13%)(17%)(4%)
Sale Success Rate9 of 266 of 265 of 265 of 260 of 26
Drugs » Biotechnology

SVP, Finance and CFO:

Holdings: 272.23K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--